nfr-logonfr-logo
PROSJEKTBANKEN
Bytt til Norsk språk
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

EIC-The European Innovation Council (EIC)

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Tildelt: kr 25,2 mill.

Prosjektperiode: 2024-2028

Sted: Oslo

CL1-Health

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Tildelt: kr 44,6 mill.

Prosjektperiode: 2024-2027

Sted: Oslo og 2 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

DSTrain - Data Science Postdoctoral Training Programme

DSTrain is a 5-year postdoctoral programme that will award 36 postdoctoral fellowship positions of 36 months each in two calls over the programme period within the overarching frame of data science. The programme will train researchers and innovators with disciplinary, interdisciplinary and trans...

Tildelt: kr 52,1 mill.

Prosjektperiode: 2024-2028

Sted: Akershus og 12 andre

CL1-Health

ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

ENT1DEP aims to define causal links between infections and NCDs by focusing on enterovirus (EV) infections and type 1 diabetes (T1D), a robust association without proof of causality. Causality is addressed by a multidisciplinary, multi-layer approach, using in-vitro and in-vivo models, unique hum...

Tildelt: kr 7,3 mill.

Prosjektperiode: 2024-2027

Sted: Oslo

CL1-Health

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

Tildelt: kr 12,2 mill.

Prosjektperiode: 2024-2028

Sted: Oslo

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Tildelt: kr 29,6 mill.

Prosjektperiode: 2023-2028

Sted: Rogaland og 5 andre

CL5-Climate, Energy and Mobility

From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels

REFINE develops and demonstrates a system of artificial photosynthesis by combining both dark and light-dependent reactions for the direct production of high energy density and essential chemicals, such as alcohols. To achieve this, a direct hydrogen storage into hydrocarbons through CO2 capture ...

Tildelt: kr 21,8 mill.

Prosjektperiode: 2023-2027

Sted: Oslo og 2 andre

ERC-European Research Council (ERC)

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

Tildelt: kr 1,7 mill.

Prosjektperiode: 2023-2025

Sted: Akershus og 2 andre

CL1-Health

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Tildelt: kr 18,2 mill.

Prosjektperiode: 2023-2028

Sted: Oslo

CL1-Health

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Tildelt: kr 0,10 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

CL1-Health

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

Tildelt: kr 3,2 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

International Study for Treatment of Childhood Relapsed ALL 2020

International Study for Treatment of Childhood Relapsed ALL 2020

Tildelt: kr 1,1 mill.

Prosjektperiode: 2023-2028

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Glioblastoma multiforme (GBM) is the most common and deadly type of primary brain tumour, carrying a dire prognosis with a median survival of 14.6 months for patients undergoing standard treatments. The causes of poor clinical prognosis are late diagnosis, diffuse infiltration, pseudo necrosis, h...

Tildelt: kr 2,9 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

Establishing of Cancer Mission Hubs: Networks and Synergies

Cancer- healthcare, research and innovation face core common challenges, such as fragmentation of initiatives and distancing from important stakeholders, requiring coordinated solutions. These challenges are recognized in Horizon Europe’s Cancer Mission Implementation Plan and in Europe’s Beating...

Tildelt: kr 3,7 mill.

Prosjektperiode: 2023-2026

Sted: Trøndelag - Trööndelage og 3 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Metastatic melanoma is a hard-to-treat disease and it remains as one of the most worrisome cancer. There is an urgent need to improve the current therapies (chemotherapy, radiotherapy) that have a limited efficacy. A single therapy is not efficient to tackle metastatic melanoma and a combination ...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

WIDENING-Widening participation and spreading excellence

Diabetes, obesity and the Kidney

Chronic kidney disease is a major cause of morbidity and mortality in the EU. About 10-15% of the EU population has chronic kidney disease (CKD) and this number is expected to increase in the future decades. Diabetes is today the main cause of CKD in the EU: about, 30% of the cases with dialysi...

Tildelt: kr 2,9 mill.

Prosjektperiode: 2023-2025

Sted: Oslo

ERC-European Research Council (ERC)

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

When an organism experiences physiological stresses, such as nutrient starvation, it activates several mechanisms to promote its survival. One of these mechanisms is autophagy, which is a catabolic pathway conserved from yeast to man that functions as a recycling system during normal physiology, ...

Tildelt: kr 15,2 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

CL1-Health

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Tildelt: kr 7,6 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Tildelt: kr 21,1 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

EIC-The European Innovation Council (EIC)

Supervised morphogenesis in gastruloids

Supervised morphogenesis in gastruloids

Tildelt: kr 13,6 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

CL1-Health

Psych-STRATA - A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness

A key problem in Mental Health is that up to one third of patients suffering from major mental disorders develop resistance against drug therapy. However, patients showing early signs of treatment resistance (TR) do not receive adequate early intensive pharmacological treatment but instead they u...

Tildelt: kr 6,6 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

CL1-Health

Developing and implementing innovative Patient-Centred Care Pathways for cancer patients

Developing and implementing innovative Patient-Centred Care Pathways for cancer patients

Tildelt: kr 22,9 mill.

Prosjektperiode: 2022-2027

Sted: Oslo og 3 andre

CL1-Health

Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers

Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers

Tildelt: kr 3,6 mill.

Prosjektperiode: 2022-2026

Sted: Oslo

CL1-Health

OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE

OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE

Tildelt: kr 32,0 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

CL1-Health

Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care

Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care

Tildelt: kr 11,1 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment

Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brain tumour. It has a universally fatal prognosis with 85% of patients dying within two years. Effective precision medicine therapies are thus urgently required. This can only be achieved by ...

Tildelt: Skjult

Prosjektperiode: 2022-2026

Sted: Oslo

CL1-Health

A clinical research network to improve the management of Monkeypox virus disease

A clinical research network to improve the management of Monkeypox virus disease

Tildelt: kr 6,6 mill.

Prosjektperiode: 2022-2026

Sted: Oslo

CL1-Health

Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.

Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.

Tildelt: kr 34,8 mill.

Prosjektperiode: 2022-2026

Sted: Oslo og 2 andre

INFRA-Research infrastructures

eBRAIN-Health - Actionable Multilevel Health Data

eBRAIN-Health - Actionable Multilevel Health Data

Tildelt: kr 12,4 mill.

Prosjektperiode: 2022-2026

Sted: Oslo

CL1-Health

Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology

There is an increasing prevalence of chronic diseases caused by undesired immune reactions (>10%) with high burden for the both patients (chronicity, organ failure, early death, decreased QoL) and society (EU:>100 bn €/a direct health costs) as current therapies are limited in efficacy and do not...

Tildelt: kr 5,6 mill.

Prosjektperiode: 2022-2026

Sted: Oslo

123